A carregar...
Rituximab induces Interleukin-6 production by human B cells
OBJECTIVE: Rituximab (RTX), an anti-CD20 monoclonal antibody, is highly effective in the treatment of several autoimmune diseases. The mechanism by which RTX treatment improves Rheumatoid Arthritis and ANCA-Associated Vasculitis is not easily related to B cell depletion. We have shown that RTX media...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4211955/ https://ncbi.nlm.nih.gov/pubmed/25080282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.38798 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|